CME Group, the world's largest derivatives exchange, intends to sue the U.S. Commodity Futures Trading Commission (CFTC) after it approved Bitcoin perpetual futures trading on Kalshi, a prediction market platform. CME argues that these contracts should be classified as swaps under the Dodd-Frank Act, not futures, and claims that the CFTC's approval blurs regulatory distinctions. CEO Terry Duffy warns that Bitcoin perpetual futures pose risks to retail investors due to high leverage and automatic liquidation, while critics see CME's move as an attempt to block competition from newer crypto platforms. The case highlights tensions between traditional exchanges and emerging crypto markets, with potential implications for regulation and market access in the U.S.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
